Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in Hepatitis C Virus Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study

Authors

P. Kwo
N. Gitlin
R. Nahass
D. Bernstein, Zucker School of Medicine at Hofstra/Northwell
K. Etzkorn
S. Rojter
E. Schiff
M. Davis
P. Ruane
J. Witek
+8 additional authors

Publication Date

2016

Journal Title

Hepatology

Volume Number

64

Issue Number

2

Pages

370 - 380

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Hepatology

Additional Departments

Science Education

PMID

26799692

DOI

10.1002/hep.28467